• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Machine Learning Can Predict Intradialytic Hypotension During Hemodialysis

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 6, 2024.

WEDNESDAY, Nov. 6, 2024 -- Clinical data and machine learning can help to predict intradialytic hypotension (IDH) for patients undergoing hemodialysis, according to a study published online Sept. 14 in the Journal of Kidney Care.

Shamsul K. Masum, Ph.D., from the University of Portsmouth in the United Kingdom, and colleagues investigated the scope of machine learning techniques in predicting IDH by analyzing various standard clinical variables measured by clinicians. The dataset included 73,323 hemodialysis sessions (3,944 patients) with 36,662 IDH events seen at 10 centers during 2000 to 2020.

The researchers found that systolic blood pressure (SBP) and diastolic BP (DBP) were key predictor variables. Predialysis, patients with IDH had lower SBP, as well as a greater percentage drop in SBP during dialysis. Similarly, people with IDH had lower predialysis DBP and a greater percentage drop in their DBP. IDH probability increased with lower pre-SBP, greater delta-systolic, and increased weight loss. Highest specificity (73.9 percent) and highest overall predictive accuracy (75.5 percent) were seen with a machine learning model with Random Forest. However, a model with Bidirectional Long Short-Term Memory (Bi-LSTM) achieved the highest sensitivity (78.5 percent) in predicting IDH. In a separate validation dataset, the Bi-LSTM model achieved accuracy of 74.09 percent, sensitivity of 74.81 percent, specificity of 73.3 percent, and a receiver operating characteristic-area under the curve (ROC-AUC) of 0.816. Based only on predialysis data, the prediction performance dropped to accuracy of 68.60 percent, specificity of 69.81 percent, sensitivity of 67.40 percent, and an ROC-AUC of 0.757.

"A prediction model using machine learning algorithms offers great promise as a tool in identifying patients at risk of IDH in advance," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.